Cathie Wood's ARK Invest increased positions in several technology, healthcare and digital asset companies during the week ended July 10, while reducing holdings in select semiconductor and genomics names.
Space Exploration Technologies NASDAQ:SPCX represented the firm's largest purchase by value, with about $52.1 million deployed across multiple ARK exchange-traded funds. ARK also added shares of Eli Lilly NYSE:LLY, Meta Platforms NASDAQ:META, X-Energy NASDAQ:XE, Coinbase Global NASDAQ:COIN and Circle Internet Group NYSE:CRCL, reflecting continued interest in artificial intelligence, healthcare and cryptocurrency-related businesses.
On the selling side, ARK reduced holdings in Advanced Micro Devices NASDAQ:AMD, Roku (ROKU), Robinhood Markets NASDAQ:HOOD, Deere (DE) and Iridium Communications NASDAQ:IRDM. The investment manager also cut exposure to several genomics companies, including Natera (NTRA), Illumina (ILMN), Twist Bioscience (TWST), 10x Genomics (TXG) and BioNTech (BNTX), as it continued portfolio rebalancing ahead of the second-quarter earnings season.